Growth Metrics

Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $982.0 million.

  • Quest Diagnostics' Other Non-Current Liabilities rose 1021.32% to $982.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $982.0 million, marking a year-over-year increase of 1021.32%. This contributed to the annual value of $938.0 million for FY2024, which is 707.76% up from last year.
  • Quest Diagnostics' Other Non-Current Liabilities amounted to $982.0 million in Q3 2025, which was up 1021.32% from $890.0 million recorded in Q2 2025.
  • Quest Diagnostics' Other Non-Current Liabilities' 5-year high stood at $982.0 million during Q3 2025, with a 5-year trough of $728.0 million in Q2 2022.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $817.0 million (2024), whereas its average is $842.2 million.
  • Per our database at Business Quant, Quest Diagnostics' Other Non-Current Liabilities crashed by 1187.65% in 2022 and then soared by 2376.37% in 2023.
  • Quest Diagnostics' Other Non-Current Liabilities (Quarter) stood at $792.0 million in 2021, then increased by 2.53% to $812.0 million in 2022, then rose by 7.88% to $876.0 million in 2023, then rose by 7.08% to $938.0 million in 2024, then grew by 4.69% to $982.0 million in 2025.
  • Its Other Non-Current Liabilities was $982.0 million in Q3 2025, compared to $890.0 million in Q2 2025 and $917.0 million in Q1 2025.